$ODRS
Outdoor Specialty Products, Inc.

2024 Q2 Form 10-Q Financial Statement

#000121390024043556 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q3
Revenue $52.00 $65.00
YoY Change -66.45% -66.67%
Cost Of Revenue $5.00 $6.00
YoY Change -64.29% -70.0%
Gross Profit $47.00 $59.00
YoY Change -66.67% -66.29%
Gross Profit Margin 90.38% 90.77%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $8.210K $8.732K
YoY Change 40.17% -25.0%
Operating Profit -$8.163K -$8.673K
YoY Change 42.81% -24.37%
Interest Expense $1.145K
YoY Change 47.93%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$9.308K -$9.759K
YoY Change 43.42% -19.84%
Net Earnings / Revenue -17900.0% -15013.85%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 5.284M shares 5.284M shares 5.284M shares
Diluted Shares Outstanding 5.284M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $2.450K $3.241K $3.162K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $3.649K $3.654K $3.661K
Prepaid Expenses $1.920K $3.360K $458.00
Receivables
Other Receivables
Total Short-Term Assets $8.019K $10.26K $7.281K
YoY Change -0.43% 5.9% 14.9%
LONG-TERM ASSETS
Property, Plant & Equipment $4.278K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $6.508K $0.00 $0.00
YoY Change 51.88% -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $8.019K $10.26K $7.281K
Total Long-Term Assets $6.508K $0.00 $0.00
Total Assets $14.53K $10.26K $7.281K
YoY Change 17.73% -27.12% -33.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.250K $2.310K
YoY Change
Accrued Expenses $8.185K $7.040K $5.012K
YoY Change 95.63% 106.45% 140.04%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $148.5K $135.0K $105.7K
YoY Change 58.89% 52.1% 68.13%
SHAREHOLDERS EQUITY
Retained Earnings -$238.5K -$229.2K -$202.9K
YoY Change 28.47% 27.93% 29.7%
Common Stock $5.285K $5.285K $5.285K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$134.0K -$124.7K -$98.40K
YoY Change
Total Liabilities & Shareholders Equity $14.53K $10.26K $7.281K
YoY Change 17.73% -27.12% -33.37%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q3
OPERATING ACTIVITIES
Net Income -$9.308K -$9.759K
YoY Change 43.42% -19.84%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5284318 shares
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56301
dei Entity Registrant Name
EntityRegistrantName
OUTDOOR SPECIALTY PRODUCTS, INC.
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-4854952
dei Entity Address Address Line1
EntityAddressAddressLine1
3842 Quail Hollow Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84109
dei City Area Code
CityAreaCode
(801)
dei Local Phone Number
LocalPhoneNumber
560-5184
dei Security12b Title
Security12bTitle
None
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5284318 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3241 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3162 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3360 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
458 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
3654 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
3661 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
10255 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
7281 usd
CY2024Q1 us-gaap Assets
Assets
10255 usd
CY2023Q3 us-gaap Assets
Assets
7281 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2310 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7040 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5012 usd
CY2024Q1 us-gaap Liabilities
Liabilities
134953 usd
CY2023Q3 us-gaap Liabilities
Liabilities
105682 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5284318 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5284318 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5284318 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5284318 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
5285 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
5285 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
99232 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
99232 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-229215 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-202918 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-124698 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-98401 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10255 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7281 usd
CY2024Q1 us-gaap Revenues
Revenues
65 usd
CY2023Q1 us-gaap Revenues
Revenues
195 usd
us-gaap Revenues
Revenues
78 usd
us-gaap Revenues
Revenues
325 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
59 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
175 usd
us-gaap Gross Profit
GrossProfit
71 usd
us-gaap Gross Profit
GrossProfit
293 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8732 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11643 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24340 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21696 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
8732 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
11643 usd
us-gaap Operating Expenses
OperatingExpenses
24340 usd
us-gaap Operating Expenses
OperatingExpenses
21696 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8673 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-11468 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-24269 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-21403 usd
CY2024Q1 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
1086 usd
CY2023Q1 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
707 usd
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
2028 usd
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
1322 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-9759 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-12175 usd
us-gaap Net Income Loss
NetIncomeLoss
-26297 usd
us-gaap Net Income Loss
NetIncomeLoss
-22725 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5284318 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5284318 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5284318 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5284318 shares
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-51929 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-10550 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-62479 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-12175 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-74654 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-98401 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-16538 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-114939 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-9759 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-124698 usd
us-gaap Net Income Loss
NetIncomeLoss
-26297 usd
us-gaap Net Income Loss
NetIncomeLoss
-22725 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
204 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2902 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2750 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-32 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2310 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2028 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1322 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29474 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23917 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
29553 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
24546 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29553 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24546 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
79 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
629 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3162 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1241 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3241 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1870 usd
osp Line Of Credit Related Party
LineOfCreditRelatedParty
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTE 3 – LINE OF CREDIT – RELATED PARTY</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">During the six months ended March 31, 2024, the Company amended the revolving promissory note agreement with its related party to extend the maturity date to December 31, 2024 and increase the maximum principal indebtedness to $127,500. The revolving promissory note bears interest at the rate of 3.5%. The Company received proceeds under the line of credit of $26,000 during the six months ended March 31, 2024, resulting in principal balances of $109,521 and $83,521, with accrued interest of $6,172 and $4,444, at March 31, 2024 and September 30, 2023, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Also, during the six months ended March 31, 2024, the Company amended the revolving promissory note agreement with another principal stockholder to extend the maturity date to December 31, 2024 and increase the maximum principal indebtedness to $22,500. The revolving promissory note bears interest at the rate of 3.5% per annum. The Company received proceeds under the line of credit of $3,553 during the six months ended March 31, 2024, resulting in balances of $18,392 and $14,839, with accrued interest of $868 and $568, at March 31, 2024, and September 30, 2023, respectively.</p>
CY2024Q1 us-gaap Long Term Debt Maturity Date
LongTermDebtMaturityDate
2024-12-31
us-gaap Line Of Credit Facility Periodic Payment Principal
LineOfCreditFacilityPeriodicPaymentPrincipal
22500 usd
us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.035 pure
us-gaap Proceeds From Secured Lines Of Credit
ProceedsFromSecuredLinesOfCredit
3553 usd
us-gaap Line Of Credit Facility Periodic Payment
LineOfCreditFacilityPeriodicPayment
18392 usd
CY2023 us-gaap Line Of Credit Facility Periodic Payment
LineOfCreditFacilityPeriodicPayment
14839 usd
us-gaap Line Of Credit Facility Increase Accrued Interest
LineOfCreditFacilityIncreaseAccruedInterest
868 usd
CY2023 us-gaap Line Of Credit Facility Increase Accrued Interest
LineOfCreditFacilityIncreaseAccruedInterest
568 usd
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
usd
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5284318 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5284318 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5284318 shares
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001610718

Files In Submission

Name View Source Status
0001213900-24-043556-index-headers.html Edgar Link pending
0001213900-24-043556-index.html Edgar Link pending
0001213900-24-043556.txt Edgar Link pending
0001213900-24-043556-xbrl.zip Edgar Link pending
ea0205467-10q_outdoor.htm Edgar Link pending
ea020546701ex31-1_outdoor.htm Edgar Link pending
ea020546701ex32-1_outdoor.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
osp-20240331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ea0205467-10q_outdoor_htm.xml Edgar Link completed
osp-20240331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
osp-20240331_def.xml Edgar Link unprocessable
osp-20240331_lab.xml Edgar Link unprocessable
osp-20240331_pre.xml Edgar Link unprocessable